JCI - Citations to PPARs in atherosclerosis: the clot thickens

Citations to this article

PPARs in atherosclerosis: the clot thickens

Antonio Castrillo, Peter Tontonoz

Antonio Castrillo, Peter Tontonoz

Published December 1, 2004
Citation Information: J Clin Invest. 2004;114(11):1538-1540. https://doi.org/10.1172/JCI23705.

View: Text | PDF

Total citations by year

Year:	2023	2022	2021	2020	2017	2016	2015	2014	2012	2009	2008	2007	Total
Citations:	1	1	1	1	2	1	1	1	2	2	1	1	15

Citation information

Citations to this article (15)

Title and authors	Publication	Year
An insight to treat cardiovascular diseases through phytochemicals targeting PPAR-α. Sharma S, Sharma D, Dhobi M, Wang D, Tewari D	Molecular and Cellular Biochemistry	2023
KLF2 alleviates endothelial cell injury and inhibits the formation of THP‑1 macrophage‑derived foam cells by activating Nrf2 and enhancing autophagy Tan Z, Ren H, Liu Y, Yang H, Luo Q, Deng X	Experimental and therapeutic medicine	2022
Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation Gao Z, Xu X, Li Y, Sun K, Yang M, Zhang Q, Wang S, Lin Y, Lou L, Wu A, Liu W, Nie B	Frontiers in pharmacology	2021
Sparse reduced-rank regression for integrating omics data H Hilafu, SE Safo, L Haine	BMC bioinformatics	2020
Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions BG Durgin, OA Cherepanova, D Gomez, T Karaoli, GF Alencar, JT Butcher, YQ Zhou, MP Bendeck, BE Isakson, GK Owens, JJ Connelly	American journal of physiology. Heart and circulatory physiology	2017
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α L Han, WJ Shen, S Bittner, FB Kraemer, S Azhar	Future Cardiology	2017
Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN	Diabetes care	2016
Polydatin Inhibits Formation of Macrophage-Derived Foam Cells M Wu, M Liu, G Guo, W Zhang, L Liu	Evidence-Based Complementary and Alternative Medicine	2015
A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity W Liu, B Wang, H Ding, DW Wang, H Zeng	International journal of molecular medicine	2014
Nonhuman primates and other animal models in diabetes research. Harwood HJ Jr, Listrani P, Wagner JD	Journal of diabetes science and technology	2012
25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARγ signaling in human THP-1 macrophages Xu L, Shen S, Ma Y, Kim JK, Rodriguez-Agudo D, Heuman DM, Hylemon PB, Pandak WM, Ren S	American journal of physiology. Endocrinology and metabolism	2012
TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation S Xie, YF Lee, E Kim, LM Chen, J Ni, LY Fang, S Liu, SJ Lin, JI Abe, B Berk, FM Ho, C Chang	Proceedings of the National Academy of Sciences	2009
Macrophage activation induces formation of the anti-inflammatory lipid cholesteryl-nitrolinoleate FERREIRA AM, FERRARI MI, TROSTCHANSKY A, BATTHYANY C, SOUZA JM, ALVAREZ MN, LÓPEZ GV, BAKER PR, SCHOPFER FJ, O\u2019DONNELL V, FREEMAN BA, RUBBO H	Biochemical Journal	2009
Nuclear Receptors and Inflammatory Diseases K Wang, YJ Wan	Experimental biology and medicine (Maywood, N.J.)	2008
Inhibition of Interleukin-1β-Induced Group IIA Secretory Phospholipase A2 Expression by Peroxisome Proliferator-Activated Receptors (PPARs) in Rat Vascular Smooth Muscle Cells: Cooperation between PPARβ and the Proto-Oncogene BCL-6 L Ravaux, C Denoyelle, C Monne, I Limon, M Raymondjean, KE Hadri	Molecular and cellular biology	2007

Advertisement